Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 1 Study of Topical XG005-03 in Healthy Subjects
NCT04283474Phase 1Completed
- Sponsor
- Xgene Pharmaceutical Inc.
- Start
- Feb 2020
- Primary completion
- Jan 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, single-blind trial of pregabalin naproxencarbil in pain (2 arms), sponsored by Xgene Pharmaceutical Inc. Primary endpoint: Pharmacokinetic Analyses of XG005-03. Started Feb 2020; status: completed.
02
Drugs
pregabalin naproxencarbil
03
Conditions
pain
Beyond the preview
Go deeper on NCT04283474.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04283474.